Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.1650
+0.0049 (3.06%)
Apr 1, 2025, 3:45 PM EST

Bio-Path Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-9.89-16.08-13.87-10.44-10.88
Upgrade
Depreciation & Amortization
0.160.180.180.160.15
Upgrade
Stock-Based Compensation
0.570.730.850.820.58
Upgrade
Other Operating Activities
-2.080.27---
Upgrade
Change in Accounts Payable
1.410.230.7-0.2-0.08
Upgrade
Change in Other Net Operating Assets
-0.733.13-2.96-0.26-0.72
Upgrade
Operating Cash Flow
-10.58-11.54-15.1-9.92-10.96
Upgrade
Capital Expenditures
---0.02-0.07-
Upgrade
Investing Cash Flow
---0.02-0.07-
Upgrade
Issuance of Common Stock
10.72.21.7320.014.29
Upgrade
Financing Cash Flow
10.72.21.7320.014.29
Upgrade
Net Cash Flow
0.12-9.33-13.3910.02-6.67
Upgrade
Free Cash Flow
-10.58-11.54-15.12-9.99-10.96
Upgrade
Free Cash Flow Per Share
-4.40-24.13-41.55-29.70-56.98
Upgrade
Levered Free Cash Flow
-6.54-5.52-9.85-5.98-6.81
Upgrade
Unlevered Free Cash Flow
-6.54-5.52-9.85-5.98-6.81
Upgrade
Change in Net Working Capital
-0.8-3.472.170.360.72
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.